216 related articles for article (PubMed ID: 20012946)
1. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
3. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
4. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
7. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS.
Hu JD; Tang HQ; Zhang Q; Fan J; Hong J; Gu JZ; Chen JL
World J Gastroenterol; 2011 Feb; 17(6):727-34. PubMed ID: 21390142
[TBL] [Abstract][Full Text] [Related]
8. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.
Chen JL; Tang HQ; Hu JD; Fan J; Hong J; Gu JZ
World J Gastroenterol; 2010 Dec; 16(46):5874-80. PubMed ID: 21155010
[TBL] [Abstract][Full Text] [Related]
10. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry.
Yu L; Aa J; Xu J; Sun M; Qian S; Cheng L; Yang S; Shi R
J Gastroenterol Hepatol; 2011 Aug; 26(8):1290-7. PubMed ID: 21443661
[TBL] [Abstract][Full Text] [Related]
12. A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria.
Xiong X; Sheng X; Liu D; Zeng T; Peng Y; Wang Y
Anal Bioanal Chem; 2015 Nov; 407(29):8825-33. PubMed ID: 26410738
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
14. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
Song H; Peng JS; Dong-Sheng Y; Yang ZL; Liu HL; Zeng YK; Shi XP; Lu BY
Braz J Med Biol Res; 2012 Jan; 45(1):78-85. PubMed ID: 22124703
[TBL] [Abstract][Full Text] [Related]
16. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182
[TBL] [Abstract][Full Text] [Related]
17. Metabolic disorders of fatty acids and fatty acid amides associated with human gastric cancer morbidity.
Song H; Peng JS; Yao DS; Liu DL; Yang ZL; Du YP; Xiang J
Chin Med J (Engl); 2012 Mar; 125(5):757-63. PubMed ID: 22490569
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced conditioned place preference in mice: metabolomic profiling of brain tissue to find "molecular switch" of drug abuse by gas chromatography/mass spectrometry.
Meng J; Zhang X; Wu H; Bu J; Shi C; Deng C; Mao Y
Anal Chim Acta; 2012 Jan; 710():125-30. PubMed ID: 22123121
[TBL] [Abstract][Full Text] [Related]
20. Differential Tissue Metabolic Signatures in IgG4-Related Ophthalmic Disease and Orbital Mucosa-Associated Lymphoid Tissue Lymphoma.
Shimizu H; Usui Y; Wakita R; Aita Y; Tomita A; Tsubota K; Asakage M; Nezu N; Komatsu H; Umazume K; Sugimoto M; Goto H
Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):15. PubMed ID: 33439228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
